GE Healthcare Technologies (GEHC) said Thursday it launched a 3D ultrasound with advanced artificial intelligence features called Invenia Automated Breast Ultrasound Premium, that helps detect breast cancer earlier and better in women with dense breasts.
The technology uses AI to optimize the screening capabilities of clinicians and improve early detection of breast cancer in women with dense breast tissue, the company said.
The technology, which has received premarket approval from the US Food and Drug Administration, will be launched in "key countries" throughout the year, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.